The Europe medical cannabis market is projected to reach US$ 13,801.0 million by 2028, up from US$ 492.1 million in 2021, growing at a compound annual growth rate (CAGR) of 61.1% from 2022 to 2028. This significant growth is primarily driven by the increasing volume of research on the medicinal applications of cannabis, along with rising government funding and policy support for its use in healthcare. However, the ongoing illegal use of cannabis as a recreational street drug poses a challenge and may impede the market’s progress.
Download Full PDF Sample Copy of Market Report @- https://www.businessmarketinsights.com/sample/TIPRE00018766
Strategic Insights: Europe Medical Cannabis Market
Strategic insights into the European medical cannabis market deliver data-driven analysis of the evolving industry landscape. These insights highlight emerging trends, spotlight key players, and uncover regional dynamics that shape the market.
Designed to provide actionable recommendations, these insights enable stakeholders to differentiate themselves by identifying underserved market segments and crafting unique value propositions. By leveraging advanced data analytics, stakeholders—whether investors, manufacturers, or regulators—can anticipate market developments and align their strategies accordingly.
With a forward-looking perspective, these insights support long-term positioning in a dynamic and fast-growing sector. Ultimately, they empower decision-makers to drive profitability, enhance competitiveness, and achieve sustainable business objectives across the European medical cannabis landscape.
Europe Medical Cannabis Report Scope
| Attribute | Details |
| Market Size (2021) | US$ 492.1 Million |
| Market Size (2028) | US$ 13,801.0 Million |
| CAGR (2022–2028) | 61.1% |
| Historical Data | 2019–2020 |
| Forecast Period | 2022–2028 |
| Segments (By Product Type) | Flowers, Concentrates, Tablets, Cannabis Oil & Topical Ointments, Capsules, Beverages & Edibles |
| Segments (By Medical Application) | Pain Management, Neurological Health, Mental Health |
| Segments (By Compound) | THC-Dominant, CBD-Dominant, Balanced THC & CBD |
| Regions Covered | UK, Germany, France, Russia, Italy, Rest of Europe |
| Key Companies | Organigram, Aurora, Canopy Growth, Tilray, etc. |
Europe Medical Cannabis – Regional Insights
The geographic scope of the Europe medical cannabis market encompasses the diverse regions in which companies operate and compete. Understanding local distinctions—such as regional consumer preferences, economic conditions, and regulatory frameworks—is essential for tailoring effective market strategies. For example, differences in product demand, including specific formulations, delivery methods, or packaging standards, may vary significantly from one country to another. Additionally, navigating the complex and evolving legal landscape across European nations is critical to maintaining compliance and competitiveness. By identifying underserved areas or adapting offerings to meet localized needs, businesses can broaden their reach. A focused regional strategy enables more efficient resource allocation, precise marketing efforts, and stronger positioning against local competitors, ultimately driving sustainable growth across the European market.
Government Initiatives and Country Analysis Supporting the Growth of the Medical Cannabis Market in Europe
Governments across Europe are increasingly supporting research and development (R&D) in the medical cannabis sector, particularly in response to emerging healthcare challenges such as COVID-19. For instance, in September 2020, EXMceuticals Inc. announced that it had secured funding to advance R&D efforts for its landmark COVID-19 research initiative. The European Union and the Portuguese government jointly allocated approximately US$ 353,000 (EUR 302,000) to support the company’s BioBlockCOVID project. This project focuses on the development of functional, natural, and innovative biocide formulations designed to target specific molecules associated with COVID-19. Such funding is expected to enhance ongoing research and foster the development of new therapeutic techniques, further propelling the medical cannabis market during the forecast period.
Country Spotlight: Germany
Germany has emerged as a key player in the European medical cannabis market. The country legalized the prescription of medical cannabis in March 2017, leading to a steady rise in both patient access and product variety. German pharmacies have been dispensing increasing volumes of medical cannabis, with sales rising from 33.8 kg in the first half of 2015 to 61.8 kg in the first half of 2016, according to the Federal Ministry of Health.
The country has also witnessed a growing number of clinical studies evaluating the effectiveness of medical cannabis and individual cannabinoids in treating various conditions. Notably, Sativex, a cannabis-based medication, was approved in Germany in 2011 as an add-on therapy for patients experiencing moderate-to-severe spasticity due to multiple sclerosis (MS). Clinical trials have demonstrated its cost-effectiveness and therapeutic benefit for MS patients, supporting its broader adoption in clinical practice.
Can you see this our reports –
Europe Halal Cosmetics Market – Europe Halal Cosmetics Market Trends, Size, Segment and Growth by Forecast to 2030
Europe Stevia Market – Europe Stevia Market Trends, Size, Segment and Growth by Forecast to 2030
Europe Neurovascular Devices Market – Europe Neurovascular Devices Market Trends, Size, Segment and Growth by Forecast to 2030
Europe Dental Market – Home
Europe Railway Cyber Security Market – Europe Railway Cyber Security Market Trends, Size, Segment and Growth by Forecast to 2030
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
